DYP-688

N/A

Report date: 2022/11/07 19:20:10
NME

Base Information

Drug NameDYP-688
Drug Alias NameDYP-688
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGuanine nucleotide-binding protein G(q) subunit alpha inhibitorsGuanine nucleotide-binding protein subunit alpha-11 inhibitors
TargetsGuanine nucleotide-binding protein G(q) subunit alphaGuanine nucleotide-binding protein subunit alpha-11
Therapy Area/IndicationsUveal melanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsAustralia +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsUveal melanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A